Actively Recruiting

Age: 18Years +
MALE
NCT06320223

PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer

Led by University Hospital, Essen · Updated on 2024-03-20

10000

Participants Needed

1

Research Sites

573 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Background: PROMISE criteria have been defined for standardized reporting of Prostate-Specific Membrane Antigen (PSMA) PET whole-body stage of prostate cancer. PSMA PET disease extent by PROMISE has been associated with oncologic outcome. Need: Improved prognostication across various stages of prostate cancer is needed for management guidance and study design. Aim: 1. To assess the prognostic value of PSMA PET 2. To compare the prognostic value of PSMA PET with clinical prognostic scores in patients with prostate cancer at various disease stages Inclusion: * Adult patients with * biopsy/histo proven prostate cancer who * underwent PSMA PET (any type) * for staging or re-staging at any stage and who * have at least 3-year overall survival follow-up data available will be included consecutively. Exclusion: * Patients with neuroendocrine prostate cancer * Patients with metastasized or disseminated malignancy other than prostate cancer

CONDITIONS

Official Title

PROMISE PET Registry on PSMA-PET and Outcome in Prostate Cancer

Who Can Participate

Age: 18Years +
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patients with biopsy or histopathology confirmed prostate cancer
  • Patients who have undergone any type of PSMA PET scan for staging or restaging at any disease stage
  • Patients with available follow-up data for at least 3 years overall survival
  • Male patients
Not Eligible

You will not qualify if you...

  • Patients with neuroendocrine prostate cancer
  • Patients with metastatic or widespread cancers other than prostate cancer

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

University Hospital Essen

Essen, Germany, 45147

Actively Recruiting

Loading map...

Research Team

W

Wolfgang P Fendler, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here